Oana Brosteanu

3.0k total citations
37 papers, 1.2k citations indexed

About

Oana Brosteanu is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Oana Brosteanu has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Pathology and Forensic Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Oana Brosteanu's work include Lymphoma Diagnosis and Treatment (8 papers), Coronary Interventions and Diagnostics (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Oana Brosteanu is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Coronary Interventions and Diagnostics (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Oana Brosteanu collaborates with scholars based in Germany, United States and Netherlands. Oana Brosteanu's co-authors include Dirk Hasenclever, Volker Diehl, Gerhard Schüler, Bernward Lauer, Hölger Thiele, Steffen Desch, Petra Neuhaus, Ingo Eitel, Jochen Wöhrle and Sebastian Kerber and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Oana Brosteanu

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oana Brosteanu Germany	19	409	333	330	215	211	37	1.2k
Stephanie A. Terezakis United States	25	194 0.5×	104 0.3×	500 1.5×	633 2.9×	345 1.6×	126	1.9k
Theodore Wun United States	21	212 0.5×	865 2.6×	119 0.4×	210 1.0×	361 1.7×	42	2.4k
Ranjan Pathak United States	20	157 0.4×	267 0.8×	69 0.2×	317 1.5×	299 1.4×	107	1.5k
M. Resbeut France	25	320 0.8×	152 0.5×	278 0.8×	692 3.2×	777 3.7×	104	2.4k
Vilmarie Rodriguez United States	21	120 0.3×	113 0.3×	57 0.2×	178 0.8×	352 1.7×	124	1.4k
Sylvia Kamphuis Netherlands	26	178 0.4×	69 0.2×	117 0.4×	293 1.4×	334 1.6×	52	2.1k
Manuel Carção Canada	34	104 0.3×	202 0.6×	109 0.3×	307 1.4×	589 2.8×	188	4.5k
Kevin O′Regan United States	16	133 0.3×	83 0.2×	234 0.7×	388 1.8×	324 1.5×	39	1.1k
Tracy Y. Zhu Hong Kong	30	182 0.4×	114 0.3×	156 0.5×	44 0.2×	252 1.2×	82	2.3k
Jacob A. Miller United States	27	525 1.3×	78 0.2×	112 0.3×	668 3.1×	722 3.4×	104	1.9k

Countries citing papers authored by Oana Brosteanu

Since Specialization

Citations

This map shows the geographic impact of Oana Brosteanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oana Brosteanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oana Brosteanu more than expected).

Fields of papers citing papers by Oana Brosteanu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oana Brosteanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oana Brosteanu. The network helps show where Oana Brosteanu may publish in the future.

Co-authorship network of co-authors of Oana Brosteanu

This figure shows the co-authorship network connecting the top 25 collaborators of Oana Brosteanu. A scholar is included among the top collaborators of Oana Brosteanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oana Brosteanu. Oana Brosteanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasenclever, Dirk, et al.. (2017). EFFECT of daily antiseptic body wash with octenidine on nosocomial primary bacteraemia and nosocomial multidrug-resistant organisms in intensive care units: design of a multicentre, cluster-randomised, double-blind, cross-over study. BMJ Open. 7(11). e016251–e016251. 11 indexed citations

Pfirrmann, Daniel, Suzan Tug, Oana Brosteanu, et al.. (2017). Internet-based perioperative exercise program in patients with Barrett’s carcinoma scheduled for esophagectomy [iPEP - study] a prospective randomized-controlled trial. BMC Cancer. 17(1). 413–413. 20 indexed citations

Fuernau, Georg, Ingo Eitel, Jochen Wöhrle, et al.. (2014). Impact of Long-Term Statin Pretreatment on Myocardial Damage in ST Elevation Myocardial Infarction (from the AIDA STEMI CMR Substudy). The American Journal of Cardiology. 114(4). 503–509. 10 indexed citations

Rehák, Matúš, et al.. (2013). Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefe s Archive for Clinical and Experimental Ophthalmology. 252(5). 745–752. 29 indexed citations

Wiegand, Johannes, Heiner Wedemeyer, Annegret Franke, et al.. (2013). Treatment of acute hepatitis B with lamivudine vs. placebo: A prospective randomized multicenter trial. Zeitschrift für Gastroenterologie. 51(1). 1 indexed citations

Eitel, Ingo, Jochen Wöhrle, Sebastian Kerber, et al.. (2013). Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 61(13). 1447–1454. 143 indexed citations

Thiele, Hölger, Jochen Wöhrle, Rainer Hambrecht, et al.. (2012). Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. The Lancet. 379(9819). 923–931. 156 indexed citations

Brosteanu, Oana, et al.. (2011). Quantification of HBsAg and HBV-DNA during Therapy with Peginterferon alpha-2b plus Lamivudine and Peginterferon alpha-2b Alone in a German Chronic Hepatitis B Cohort. Zeitschrift für Gastroenterologie. 49(11). 1463–1469. 3 indexed citations

Paulus, Ursula, Sandra De Meyer, Beate Pfistner, et al.. (2008). Systematic review about data quality and protocol compliance in clinical trials. SHILAP Revista de lepidopterología. 2 indexed citations

10.

Sick, Peter, Oana Brosteanu, Matthias Ülrich, et al.. (2005). Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: The Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. American Heart Journal. 149(4). 681–688. 14 indexed citations

11.

Schneider, J.-P., C. Trantakis, Thomas Schulz, et al.. (2005). Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme—a quantitative radiological analysis. Neuroradiology. 47(7). 489–500. 106 indexed citations

12.

Sick, Peter, Götz Gelbrich, Uldis Kalnins, et al.. (2004). Comparison of early and late results of a Carbofilm-coated stent versus a pure high-grade stainless steel stent (the Carbostent-Trial). The American Journal of Cardiology. 93(11). 1351–1356. 24 indexed citations

13.

Brosteanu, Oana, et al.. (2004). Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin?s disease. Annals of Hematology. 83(3). 176–182. 21 indexed citations

14.

Körholz, Dieter, Alexander Claviez, Dirk Hasenclever, et al.. (2004). The Concept of the GPOH-HD 2003 Therapy Study for Pediatric Hodgkin's Disease: Evolution in the Tradition of the DAL/GPOH Studies. Klinische Pädiatrie. 216(3). 150–156. 40 indexed citations

15.

Sick, Peter, Oana Brosteanu, Josef Niebauer, Christoph Hehrlein, & Gerhard Schüler. (2002). Neointima Formation After Stent Implantation in an Experimental Model of Restenosis. PubMed. 4(1). 18–25. 12 indexed citations

16.

Carde, Patrice, Serge Koscielny, Jeremy Franklin, et al.. (2002). Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?. Annals of Oncology. 13. 86–91. 43 indexed citations

17.

Hasenclever, Dirk, et al.. (2001). Modelling of chemotherapy: The effective dose approach. Annals of Hematology. 80(S3). B89–B94. 23 indexed citations

18.

Brosteanu, Oana & Markus Löffler. (1998). Methoden kontrollierter klinischer Studien. Der Internist. 39(9). 909–916.

19.

Loeffler, Markus, Oana Brosteanu, Dirk Hasenclever, et al.. (1998). Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.. Journal of Clinical Oncology. 16(3). 818–829. 143 indexed citations

20.

Pfreundschuh, Michael, U. Rueffer, B. Lathan, et al.. (1994). Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.. Journal of Clinical Oncology. 12(3). 580–586. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact